← Back to ABT

ABBOTT LABORATORIES financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMar 2026Filed 29/04/2026Sep 2025Filed 29/10/2025Jun 2025Filed 30/07/2025Mar 2025Filed 29/04/2026Sep 2024Filed 29/10/2025Jun 2024Filed 30/07/2025Mar 2024Filed 30/04/2025Sep 2023Filed 31/10/2024
$11,164$11,369$11,142$10,358$10,635$10,377$9,964$10,143
$1,077$1,644$1,779$1,325$1,646$1,302$1,225$1,436
$0.61$0.94$1.01$0.76$0.94$0.74$0.70$0.82
1,7471,7491,7511,7471,7481,7511,7501,748

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.